# Amgen Inc. (AMGN) — Q3-2020 Earnings Results

**Report date:** 2020-10-28 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2020

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 3.17%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.37 | N/A | +16.66% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management remains positive about future opportunities despite current market challenges. They emphasized the importance of innovation.

**Key quotes:**

> Management expressed confidence in the company's long-term growth prospects.

> They highlighted ongoing investments in research and development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report shows a strong performance in EPS, exceeding expectations by a notable margin. However, the stock fell by 3.17% in reaction, likely due to the lack of revenue details and no guidance for future performance. Investors may be cautious given the uncertainty in the market.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2020_